Pharmacologic treatment options for neonatal seizures have expanded over the past 2 decades, and there is no consensus on optimal treatment strategy. We systematically reviewed the published literature to determine which medication(s) are most effective for treating neonatal seizures, by retrieving trials and observational investigations via PubMed (through August 2011) that focused on pharmacological seizure treatment of neonates (≤ 28 days old) and utilized continuous or amplitude-integrated EEG to confirm seizure diagnosis and cessation. Our search identified 557 initial articles and 14 additional studies after reference reviews, with 16 meeting inclusion criteria. Of these, 2 were randomized trials and only 3 additional investigations included comparison groups. We found limited evidence regarding the best pharmacologic treatment for neonatal seizures, but were able to devise a treatment algorithm from available data. These findings have the potential to serve as a clinical reference and to inform the design of comparative effectiveness investigations for neonatal antiepileptics.
LanskaMJLanskaDJBaumannRJKryscioRJ. A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology. 1995;45:724–732.
2.
RonenGMPenneySAndrewsW. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr. 1999;134:71–75.
3.
SalibaRMAnnegersJFWallerDK. Incidence of neonatal seizures in Harris County, Texas, 1992-1994. Am J Epidemiol. 1999;150:763–769.
4.
BlumeHKGarrisonMMChristakisDA. Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals. J Child Neurol. 2009;24:148–154.
5.
BoothDEvansDJ.Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev. 2004;(4): CD004218.
6.
WirrellEC. Neonatal seizures: to treat or not to treat?Semin Pediatr Neurol. 2005;12:97–105.
7.
SilversteinFSFerrieroDM. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol. 2008;39:77–79.
8.
PainterMJScherMSSteinAD. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341:485–489.
9.
ThorpJAO'ConnorMJonesA. Does perinatal phenobarbital exposure affect developmental outcome at age 2?Am J Perinatol. 1999;16:51.
10.
BittigauPSifringerMGenzK. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA. 2002;99:15089–15094.
11.
ForcelliPAJanssenMJViciniSGaleK. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol. 2012;72:363–372.
12.
MoherDLiberatiATetzlaffJAltmanDG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. BMJ. 2009;339:b2535.
13.
Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine. Finding What Works in Health Care: Standards for Systematic Reviews. Washington, DC: National Academy Press; 2011.
14.
MurrayDMBoylanGBAliI. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed. 2008;93:F187–F191.
15.
MaloneAAnthony RyanCFitzgeraldA. Interobserver agreement in neonatal seizure identification. Epilepsia. 2009;50:2097–2101.
16.
van RooijLGMToetMCvan HuffelenAC. Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial. Pediatrics. 2010;125:e358–e366.
17.
BoylanGRennieJChorleyG. Second-line anticonvulsant treatment of neonatal seizures. Neurology. 2004;62:486–488.
18.
Hellström-WestasLWestgrenURosenISvenningsenN. Lidocaine for treatment of severe seizures in newborn infants. Acta Paediatr Scand. 1988;77:79–84.
19.
Castro-CondeJRBorgesAAHMartinezED. Midazolam in neonatal seizures with no response to phenobarbital. Neurology. 2005;64:876–879.
20.
ShanyEBenzaqenOWatembergN. Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures. J Child Neurol. 2007;22:255–259.
21.
DeshmukhAWittertWSchnitzlerEMangurtenHH. Lorazepam in the treatment of refractory neonatal seizures: a pilot study. Am J Dis Child. 1986;140:1042.
22.
ConnellJOozeerRDe VriesL. Clinical and EEG response to anticonvulsants in neonatal seizures. Arch Dis Child. 1989;64:459–464.
23.
BonatiMMarraroGCelardoA. Thiopental efficacy in phenobarbital-resistant neonatal seizures. Dev Pharmacol Ther. 1990;15:16.
24.
MaytalJNovakGPKingKC. Lorazepam in the treatment of refractory neonatal seizures. J Child Neurol. 1991;6:319–323.
25.
ByeAFlanaganD. Electroencephalograms, clinical observations and the monitoring of neonatal seizures. J Paediatr Child Health. 1995;31:503–507.
26.
ShethRDBuckleyDJGutierrezAR. Midazolam in the treatment of refractory neonatal seizures. Clin Neuropharmacol. 1996;19:165.
UsherRShephardMLindJ. The blood volume of the newborn infant and placental transfusion. Acta Paediatrica. 1963;52:497–512.
41.
UsherRLindJ. Blood volume of the newborn premature infant. Acta Paediatrica. 1965;54:419–431.
42.
BauerKLinderkampOVersmoldH. Systolic blood pressure and blood volume in preterm infants. Arch Dis Child. 1993;69:521–522.
43.
dos SantosAMNGuinsburgRde AlmeidaMFB. Red blood cell transfusions are independently associated with intra-hospital mortality in very low birth weight preterm infants. J Pediatr. 2011;159:371–376.
44.
BlauJCaloJMDozorD. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr. 2011;158:403–409.
45.
PaulDAMackleyANovitskyA. Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics. 2011;127:635–641.
46.
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Application number NDA 21505/S-026. Available at: http://www.accessdata.fda.gov. Accessed October 5, 2012.
47.
BlumerJL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet. 1998;35:37–47.
48.
NgEKlingerGShahVTaddioA. Safety of benzodiazepines in newborns. Ann Pharmacother. 2002;36:1150–1155.
49.
SilversteinFSJensenFEInderT. Improving the treatment of neonatal seizures: National Institute of Neurological Disorders and Stroke workshop report. J Pediatr. 2008;153:12–15.
Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Center for Research Resources. Laparotomy vs. drainage for infants with necrotizing enterocolitis (NEST). Available at: http://clinicaltrials.gov/ct2/show/NCT01029353?term=nest&rank=1. Accessed October 5, 2012.
52.
National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development. Neonatal Research Network. Available at: http://neonatal.rti.org/. Accessed October 5, 2012.
53.
National Institutes of Health, National Institute of Neurological Disorders and Stroke. NeuroNEXT: Network for Excellence in Neuroscience Clinical Trials. Available at: http://www.neuronext.org/. Accessed October 5, 2012.
54.
VandenbrouckeJP. What is the best evidence for determining harms of medical treatment?Can Med Assoc J. 2006;174:645–646.
55.
ChouRAronsonNAtkinsD. AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol. 2010;63:502–512.
